STEPHANIE SKOW: Open Payments
NPI 1013938158 · LIHUE, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 28 payments from 5 companies in 2025. Trend: 2023 $177 · 2024 $578 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $140 |
| Teva Pharmaceuticals USA, Inc. | 5 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| ABBVIE INC. | 1 | $23 |
Products named: INGREZZA, CAPLYTA, AUSTEDO XR, ABILIFY MAINTENA, REXULTI, VRAYLAR.
Industry payments across HI — which companies pay providers there.
